The FDA has extended approval to Abilify MyCite, the first digitized pill to be outfitted with a sensor that can track a patient’s pill ingestion schedule.
Archive | FDA RSS feed for this section
The FDA has given MDMA the okay to advance to Phase II trials in PTSD treatment, labeling the drug as a breakthrough in the study of PTSD remedy.
New research reveals MDMA-aided psychotherapy is able to ease symptoms synonymous with PTSD.
MDMA-assisted psychotherapy may be imminent: ‘We’re on track for MDMA to be approved by the FDA by 2021′
FDA is strongly considering full authorization of MDMA-assisted psychotherapy in 2021.
© 2013 SimplyNeon. All Rights Reserved.
Designed by OhhWord Media